Literature DB >> 7622107

Observer agreement on interpreting colposcopic images of CIN.

E H Hopman1, F J Voorhorst, P Kenemans, C J Meyer, T J Helmerhorst.   

Abstract

The purpose of this work was to study intraobserver and interobserver variation in the interpretation of colposcopic images of cervical intraepithelial neoplasia (CIN). Twenty-three experienced colposcopists were asked to assess colposcopic images presented on slides and to select the biopsy site. Eleven cases were independently interpreted twice with an interval of 2-3 months by all observers. No information about the cytological classification was available. In each case the "majority assessment" was considered as the standard, being "no CIN" in 2 cases, CIN I in 4 cases, CIN II in 3 cases, and CIN III in 2 cases. Intraobserver concordance was 66.7%, the kappa value was 0.54. Interobserver agreement was found to be 52.4 and 51.0% in the first and second sessions, respectively, while the mean kappa values were 0.41 and 0.33, respectively. In selecting the site for biopsy, 77.4% of all observers agreed while the same site was selected in 85.3% of cases by the individual colposcopist in the two sessions. Overall, CIN I and II interpretations revealed lower levels of agreement than no CIN or CIN III interpretations. It is concluded that observer variability in interpreting colposcopic images and selecting the site for biopsy is in the same range as observer variation in other subjective diagnostic tests such as cytology and histopathology. This variation should be taken into account in the colposcopical management of patients with abnormal cytology.

Entities:  

Mesh:

Year:  1995        PMID: 7622107     DOI: 10.1006/gyno.1995.1212

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  8 in total

1.  [Colposcopy in the diagnosis of early cervical cancer].

Authors:  W Kühn
Journal:  Pathologe       Date:  2011-11       Impact factor: 1.011

2.  ASCCP Colposcopy Standards: How Do We Perform Colposcopy? Implications for Establishing Standards.

Authors:  Alan G Waxman; Christine Conageski; Michelle I Silver; Candice Tedeschi; Elizabeth A Stier; Barbara Apgar; Warner K Huh; Nicolas Wentzensen; L Stewart Massad; Michelle J Khan; Edward J Mayeaux; Mark H Einstein; Mark H Schiffman; Richard S Guido
Journal:  J Low Genit Tract Dis       Date:  2017-10       Impact factor: 1.925

3.  HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study.

Authors:  Murat Gök; Daniëlle A M Heideman; Folkert J van Kemenade; Johannes Berkhof; Lawrence Rozendaal; Johan W M Spruyt; Feja Voorhorst; Jeroen A M Beliën; Milena Babovic; Peter J F Snijders; Chris J L M Meijer
Journal:  BMJ       Date:  2010-03-11

4.  Liquid-based cytology for primary cervical cancer screening: a multi-centre study.

Authors:  J Monsonego; A Autillo-Touati; C Bergeron; R Dachez; J Liaras; J Saurel; L Zerat; P Chatelain; C Mottot
Journal:  Br J Cancer       Date:  2001-02-02       Impact factor: 7.640

5.  Standardized Digital Colposcopy with Dynamic Spectral Imaging for Conservative Patient Management.

Authors:  Angelika Kaufmann; Christina Founta; Emmanouil Papagiannakis; Raj Naik; Ann Fisher
Journal:  Case Rep Obstet Gynecol       Date:  2017-12-25

6.  Colposcopic evaluation of neoplasic and preneoplasic lesions of the cervix - a retrospective study.

Authors:  A Comanescu; D Iliescu; Maria Comanescu; N Cernea; L Mogoanta; Cristiana Simionescu
Journal:  Curr Health Sci J       Date:  2010-06-23

7.  Triaging borderline/mild dyskaryotic Pap cytology with p16/Ki-67 dual-stained cytology testing: cross-sectional and longitudinal outcome study.

Authors:  M H Uijterwaal; B I Witte; F J Van Kemenade; D Rijkaart; R Ridder; J Berkhof; G A M A Balfoort-van der Meij; M C G Bleeker; P J F Snijders; C J L M Meijer
Journal:  Br J Cancer       Date:  2014-02-11       Impact factor: 7.640

8.  HPV-positive women with normal cytology remain at increased risk of CIN3 after a negative repeat HPV test.

Authors:  Nicole J Polman; Nienke J Veldhuijzen; Daniëlle A M Heideman; Peter J F Snijders; Chris J L M Meijer; Johannes Berkhof
Journal:  Br J Cancer       Date:  2017-09-07       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.